HB8067, titled the Candis King Hope for Sickle Cell Families Act, would direct the Secretary of Health and Human Services, through the CDC, to create a Sickle Cell Data Collection program. Under that program, HHS would award grants to states to collect and maintain data on the incidence and prevalence of sickle cell disease, the demographics of people living with the disease, and how they use healthcare services. The bill also directs grantees to coordinate with existing CDC-funded sickle cell surveillance efforts to improve standardization of data collection methods nationwide.
The bill authorizes $10 million per year for fiscal years 2027 through 2031 to support the data collection program. In addition to the surveillance component, the bill would require HHS to reinstate any covered employee of the CDC’s Division of Blood Disorders and Public Health Genomics who was removed on or after January 1, 2025, as part of a qualifying reduction in force or reorganization affecting at least 3 percent of the division within a 60-day period.
Impact
If enacted, the bill would expand federal involvement in sickle cell disease surveillance by creating a new grant-funded data collection program administered by HHS/CDC and by extending or replacing prior CDC sickle cell data efforts. It would affect state public health agencies that receive grants, requiring them to collect and report disease surveillance data and collaborate on standardized methods, and it would also impose a personnel remedy affecting CDC employees in the Division of Blood Disorders and Public Health Genomics who were removed under specified workforce actions.
Sentiment
No committee transcript or vote record is available in the provided materials, so there is no direct evidence of support or opposition from debate or roll call. Based on the bill text, the measure appears to be framed as a public health and patient-support initiative focused on improving understanding of sickle cell disease and preserving CDC expertise. The overall tone of the legislation is policy-oriented and remedial rather than controversial on its face.
Contention
The main potential point of contention is the personnel reinstatement provision, which goes beyond data collection and would require HHS to restore certain CDC employees removed in a recent reorganization or reduction in force. That could raise concerns about executive branch staffing authority, agency management, and the scope of congressional intervention in personnel decisions. A secondary issue could be the cost and administrative burden of a new state grant program, though the bill text itself does not reflect any recorded opposition or debate on those points.